---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-022228"
form_type: "8-K"
ticker: "CDT"
cik: "0001896212"
company_name: "CDT Equity Inc."
filed_at: "2024-05-31T23:59:59+00:00"
generated_at: "2026-06-01T07:15:47.074699+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Conduit Pharma gets Nasdaq deficiency notice after audit committee director resigns

## Summary
- Nasdaq notified Conduit on May 28, 2024 that audit committee now has only two independent directors.
- Non-compliance triggered by resignation of director Jennifer McNealey from Board and committees.
- Cure period runs until earlier of next annual meeting or May 13, 2025; no immediate delisting.
- Company intends to regain compliance by adding a third independent audit committee member.
- Common stock (CDT) and warrants (CDTTW) continue trading on Nasdaq during cure period.

## SEC filing metadata
- accession: 0001493152-24-022228
- form_type: 8-K
- ticker: CDT
- cik: 0001896212
- company_name: CDT Equity Inc.
- filed_at: 2024-05-31T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1896212/000149315224022228/0001493152-24-022228-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1896212/000149315224022228/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-022228
- JSON: https://secwatch.observer/filing/0001493152-24-022228.json
- Plain text: https://secwatch.observer/filing/0001493152-24-022228.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.